Cipla

• NCT06705478

  Collaborator, Phase 2, Suspended, 186 people, 26 Nov 2024

• NCT06370715

  Collaborator, Phase 4, Completed, 153 people, 17 Apr 2024

• NCT01621321

  Collaborator, Phase 2/3, Completed, 50 people, 18 Jun 2012

• NCT01373359

  Collaborator, Phase 3, Completed, 652 people, 14 Jun 2011

• Lipoprotein(a)-dependent cardiovascular risk in different populations: are thresholds the same?

  Consulting or advice, Fees or honoraria, Grants or research support, 10 Oct 2026

• Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial

  Consulting or advice, Fees or honoraria, Grants or research support, 13 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov